Home/Filings/4/0001209191-21-008268
4//SEC Filing

Hammill Kevin Austin 4

Accession 0001209191-21-008268

CIK 0001441693other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 6:17 PM ET

Size

5.5 KB

Accession

0001209191-21-008268

Insider Transaction Report

Form 4
Period: 2021-01-29
Hammill Kevin Austin
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-01-29+25,00025,000 total
    Exercise: $1.66Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest in equal installments over a period of 36 months, subject to acceleration upon achievement of performance targets.

Issuer

MARRONE BIO INNOVATIONS INC

CIK 0001441693

Entity typeother

Related Parties

1
  • filerCIK 0001739741

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 6:17 PM ET
Size
5.5 KB